alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 32.1


                            CERTIFICATION PURSUANT TO
                             18 U.S.C. SECTION 1350,
                             AS ADOPTED PURSUANT TO
                  SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

         In connection with the Annual Report of Dental Patient Care America,
Inc. (the "Company") on Form 10-KSB for the period ended December 31, 2005 as
filed with the Securities and Exchange Commission on the date hereof (the
"Report"), I, Michael Silva, Chief Executive Officer of the Company, certify,
pursuant to 18 U.S.C. ss. 1350, as adopted pursuant to ss. 906 of the
Sarbanes-Oxley Act of 2002, that:

         (1)      The Report fully complies with the requirements of section
                  13(a) or 15(d) of the Securities Exchange Act of 1934; and

         (2)      The information contained in the Report fairly presents, in
                  all material respects, the financial condition and result of
                  operations of the Company.

/s/ Michael Silva
-----------------------
Chief Executive Officer
April 4, 2006
UNPUBLISHED

UNITED STATES COURT OF APPEALS

FOR THE FOURTH CIRCUIT

No. 10-6109

UNITED STATES OF AMERICA,

Plaintiff - Appellee,

v.

MARTY BROWN,

Defendant - Appellant.

Appeal from the United States District Court for the Western 

District of Virginia, at Roanoke. James C. Turk, Senior

District Judge. (7:05-cr-00060-jct-mfu-1; 7:09-cv-80182-jctmfu)

Submitted: March 16, 2010 Decided: March 24, 2010

Before NIEMEYER, MOTZ, and DAVIS, Circuit Judges.

Dismissed by unpublished per curiam opinion.

Marty Brown, Appellant Pro Se. Ronald Andrew Bassford, 

Assistant United States Attorney, Roanoke, Virginia, for 

Appellee.

Unpublished opinions are not binding precedent in this circuit.
2

PER CURIAM:

Marty Brown seeks to appeal the district court’s order 

denying relief on his 28 U.S.C.A. § 2255 (West Supp. 2009) 

motion. The order is not appealable unless a circuit justice or 

judge issues a certificate of appealability. 28 U.S.C. 

§ 2253(c)(1) (2006). A certificate of appealability will not 

issue absent “a substantial showing of the denial of a 

constitutional right.” 28 U.S.C. § 2253(c)(2) (2006). A 

prisoner satisfies this standard by demonstrating that 

reasonable jurists would find that any assessment of the 

constitutional claims by the district court is debatable or 

wrong and that any dispositive procedural ruling by the district 

court is likewise debatable. Miller-El v. Cockrell, 537 U.S. 

322, 336-38 (2003); Slack v. McDaniel, 529 U.S. 473, 484 (2000); 

Rose v. Lee, 252 F.3d 676, 683-84 (4th Cir. 2001). We have 

independently reviewed the record and conclude that Brown has 

not made the requisite showing. Accordingly, we deny a 

certificate of appealability and dismiss the appeal. We 

dispense with oral argument because the facts and legal 

contentions are adequately presented in the materials before the 

court and argument would not aid the decisional process.

DISMISSED
**Exhibit
      32.1**





Certification
      Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 (18 U.S.C.
§1350)





I,
      Thomas
      W. Martin, Chairman, Chief Executive Officer and President of ICON Capital
      Corp., the Manager of the Registrant, in connection with the Quarterly Report
      of
      ICON Leasing Fund Eleven, LLC (the "LLC") on Form 10-Q for the period ended
      September 30, 2007, as filed with the Securities and Exchange Commission on
      the
      date hereof (the "Quarterly Report") certify, pursuant to Section 906 of the
      Sarbanes-Oxley Act of 2002, that, to the best of my knowledge:





1.
            The
                Quarterly Report fully complies with the requirements of Section
                13(a) or
                15(d) of the Securities Exchange Act of 1934 (15 U.S.C. §78m);
                and





2.
            The
                information contained in the Quarterly Report fairly presents, in
                all
                material respects, the financial condition and results of operations
                of
                the LLC.








*Dated: November
      16, 2007*





*/s/
      Thomas W. Martin*


Thomas
      W.
      Martin


Chairman,
      Chief Executive Officer and President of the Manager


(Principal
      Executive Officer)


ICON
      Capital Corp.


Manager
      of ICON Leasing Fund Eleven, LLC
[Federal Register Volume 61, Number 82 (Friday, April 26, 1996)]
[Notices]
[Page 18600]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-10478]



-----------------------------------------------------------------------


FEDERAL RESERVE SYSTEM

Sunshine Act Meeting

Agency Holding the Meeting: Board of Governors of the Federal Reserve 
System.

Time and Date: 10:00 a.m., Wednesday, May 1, 1996.

Place: Marriner S. Eccles Federal Reserve Board Building, C Street 
entrance between 20th and 2lst Streets, NW., Washington, DC 20551.

Status: Closed.

Matters to be Considered:

    1. Personnel actions (appointments, promotions, assignments, 
reassignments, and salary actions) involving individual Federal Reserve 
System employees.
    2. Any items carried forward from a previously announced meeting.

Contact Person for More Information: Mr. Joseph R. Coyne, Assistant to 
the Board; (202) 452-3204. You may call (202) 452-3207, beginning at 
approximately 5 p.m. two business days before this meeting, for a 
recorded announcement of bank and bank holding company applications 
scheduled for the meeting.

    Dated: April 24, 1996.
Jennifer J. Johnson,
Deputy Secretary of the Board.
[FR Doc. 96-10478 Filed 4-24-96; 9:48 am]
BILLING CODE 6210-01-P
#### STATE of Missouri, Respondent, v. Kevin F. BRITTON, Appellant.

No. WD 48072.

Missouri Court of Appeals, Western District.

April 5, 1994.

Frederick P. Tucker, Asst. Public Defender, Moberly, for appellant.

James B. Funk, Asst. Pros. Atty., Macon County, Macon, for respondent.

Before BERREY, P.J., and KENNEDY and ELLIS, JJ.

*ORDER*

PER CURIAM.

Defendant appeals conviction of driving while license was suspended, § 302.321, RSMo Cum.Supp.1993.

*541The judgment of conviction is affirmed. Rule 30.25(b).
Document Headings

                    Document headings vary by document type but may contain                    the following:                  
                -                       the agency or agencies that issued and signed a document                    
                -                       the number of the CFR title and the number of each part                      the document amends, proposes to amend, or is directly                      related to                    
                -                       the agency docket number / agency internal file number                    
                -                       the RIN which identifies each regulatory action listed in                      the Unified Agenda of Federal Regulatory and Deregulatory                      Actions                    

                    See the                                          Document Drafting Handbook                                        for more details.                  

###### Department of Health and Human Services

###### Food and Drug Administration

          - [Docket No. FDA-2015-E-2079]

# AGENCY:

Food and Drug Administration, HHS.

# ACTION:

Notice; correction.

# SUMMARY:

The Food and Drug Administration (FDA or Agency) published a notice in the **Federal Register** of February 12, 2018. After review of a timely request for reconsideration by the applicant of the determination of the regulatory review period of the animal drug, BRAVECTO, in that notice, FDA has determined that a revision of the **SUPPLEMENTARY INFORMATION** section is warranted. This document presents the revised regulatory review period.

# FOR FURTHER INFORMATION CONTACT:

Beverly Friedman, Office of Regulatory Policy, Food and Drug Administration, 10903 New Hampshire Ave., Bldg. 51, Rm. 6250, Silver Spring, MD 20993, 301-796-3600.

# SUPPLEMENTARY INFORMATION:

## Correction

In the **Federal Register** of February 12, 2018 (83 FR 6033), in FR Doc. 2018-02761, in the first column, the first two paragraphs under the section “II. Determination of Regulatory Review Period,” the following correction is made on page 6034:

FDA has determined that the applicable regulatory review period for BRAVECTO is 1,054 days. Of this time, 1,016 days occurred during the testing phase of the regulatory review period, while 38 days occurred during the approval phase. These periods of time were derived from the following dates:

1. *The date an exemption under section 512(j) of the FD&C Act (21 U.S.C. 360b(j)) became effective:* June 28, 2011. The applicant claims February 19, 2010, as the date the investigational new animal drug application (INAD) became effective. However, after consideration of additional information presented by the applicant in response to the **Federal Register** notice (83 FR 6033), FDA has determined that the start of the testing phase was June 28, 2011, which was the date the first major health or environmental effects test began.

Dated: June 3, 2021.

Lauren K. Roth,

Acting Principal Associate Commissioner for Policy.

[FR Doc. 2021-12284 Filed 6-10-21; 8:45 am]

BILLING CODE 4164-01-P
NOT FOR PUBLICATION

UNITED STATES COURT OF APPEALS

FOR THE NINTH CIRCUIT

THOMAS JOHN HEILMAN,

Plaintiff-Appellant,

 v.

A. DILLEN, official capacity; et al.,

Defendants-Appellees.

No. 15-56852

D.C. No. 2:14-cv-06298-JVS-CW

MEMORANDUM*

Appeal from the United States District Court

for the Central District of California

James V. Selna, District Judge, Presiding

Submitted April 11, 2017**

Before: GOULD, CLIFTON, and HURWITZ, Circuit Judges.

Thoman John Heilman, a California state prisoner, appeals pro se from the 

district court’s judgment dismissing his 42 U.S.C. § 1983 action for failure to pay 

the filing fee after revoking Heilman’s in forma pauperis status (“IFP”) because he 

has three strikes under the Prison Litigation Reform Act, 28 U.S.C. § 1915(g). We 

 

* This disposition is not appropriate for publication and is not precedent 

except as provided by Ninth Circuit Rule 36-3.

** The panel unanimously concludes this case is suitable for decision 

without oral argument. See Fed. R. App. P. 34(a)(2).

FILED

APR 25 2017

MOLLY C. DWYER, CLERK

U.S. COURT OF APPEALS
2 15-56852 

have jurisdiction under 28 U.S.C. § 1291. We review de novo. Andrews v. King, 

398 F.3d 1113, 1118 & n.6 (9th Cir. 2005). We vacate and remand.

The district court revoked Heilman’s IFP status on the basis that Heilman 

had filed at least three prior actions in federal court which were dismissed for 

being frivolous or malicious, or for failing to state a claim. However, at the time of 

its decision, the district court did not have the benefit of El-Shaddai v. Zamora, 

833 F.3d 1036 (9th Cir. 2016) and Washington v. Los Angeles County Sheriff’s 

Department, 833 F.3d 1048 (9th Cir. 2016). We remand for the district court 

reconsider Heilman’s IFP status in light of these two intervening opinions.

VACATED and REMANDED.
[Federal Register Volume 61, Number 87 (Friday, May 3, 1996)]
[Notices]
[Pages 19964-19965]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-10982]



=======================================================================
-----------------------------------------------------------------------

[[Page 19965]]

RAILROAD RETIREMENT BOARD


Agency Forms Submitted for OMB Review

SUMMARY: In accordance with the Paperwork Reduction Act of 1995 (44 
U.S.C. Chapter 35), the Railroad Retirement Board has submitted the 
following proposal(s) for the collection of information to the Office 
of Management and Budget for review and approval.

Summary of Proposal(s)

    (1) Collection title: Financial Disclosure Statement.
    (2) Form(s) submitted: G-423.
    (3) OMB Number: 3220-0127.
    (4) Expiration date of current OMB clearance: June 30, 1996.
    (5) Type of request: Revision of a currently approved collection.
    (6) Respondents: Individuals or households.
    (7) Estimated annual number of respondents: 2,100.
    (8) Total annual responses: 2,100.
    (9) Total annual reporting hours: 2,975.
    (10) Collection description: Under the Railroad Retirement and the 
Railroad Unemployment Insurance Acts, the Railroad Retirement Board has 
authority to secure from an overpaid beneficiary a statement of the 
individual's assets and liabilities if waiver of the overpayment is 
requested.

ADDITIONAL INFORMATION OR COMMENTS: Copies of the form and supporting 
documents can be obtained from Chuck Mierzwa, the agency clearance 
officer (312-751-3363). Comments regarding the information collection 
should be addressed to Ronald J. Hodapp, Railroad Retirement Board, 844 
North Rush Street, Chicago, Illinois 60611-2092 and the OMB reviewer, 
Laura Oliven (202-395-7316), Office of Management and Budget, Room 
10230, New Executive Office Building, Washington, D.C. 20503.
Chuck Mierzwa,
Clearance Officer.
[FR Doc. 96-10982 Filed 5-2-96; 8:45 am]
BILLING CODE 7905-01-M
Exhibit
      32.1





**CERTIFICATION
      PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**





Solely
      for the purposes of complying with, and the extent required by 18 U.S.C.1350,
      as
      adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, the
      undersigned certifies, in his capacity as the Chief
      Executive Officer and Acting
      Chief Financial officer of Com-Guard.com,
      Inc. that, to
      his knowledge, the Annual Report of the Company on Form 10-KSB for the year
      ended June 30, 2005, fully complies with the requirements of Section 13(a)
      or
      15(d) of the Securities Exchange Act of 1934 and that the information contained
      in the report fairly presents, in all material respects, the company's financial
      condition and results of operations.




DATED:
                October 14, 2005EDWARD
                W. SAVARESE
              Chief
                Executive Officer and Acting Chief Financial
                Officer
IN THE SUPREME COURT OF THE STATE OF DELAWARE

MATTHEW M. PHLIPOT,

Defendant Below,

Appellant,

v.

STATE OF DELAWARE,

Plaintiff Below,

Appellee.

§

§ 

§ No. 187, 2018

§

§ Court Below—Superior Court

§ of the State of Delaware

§ 

§ ID. No. 0903021873 (S)

§

§

§

 Submitted: April 26, 2018

 Decided: June 14, 2018

Before VALIHURA, VAUGHN, and SEITZ, Justices.

O R D E R

This 14th day of June 2018, after careful consideration of the appellant’s 

opening brief, the appellee’s motion to affirm, and the record below, we conclude

that the judgment below should be affirmed on the basis of the Superior Court’s 

March 29, 2018 order denying the appellant’s third motion for postconviction relief.

1

 

The Superior Court did not err in concluding that the motion was procedurally barred 

by Superior Court Criminal Rule 61 and that the appellant had failed to overcome 

the procedural hurdles. 

 

1

State v. Phlipot, 2018 WL 1581195 (Del. Mar. 29, 2018).
2

NOW, THEREFORE, IT IS ORDERED that motion to affirm is GRANTED 

and the judgment of the Superior Court is AFFIRMED.

BY THE COURT:

/s/ James T. Vaughn, Jr.

Justice
[Federal Register Volume 61, Number 91 (Thursday, May 9, 1996)]
[Rules and Regulations]
[Page 21104]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-11547]



-----------------------------------------------------------------------


DEPARTMENT OF COMMERCE
50 CFR Part 672

[Docket No. 960129018-6018-01; I.D. 050396C]


Groundfish of the Gulf of Alaska; Pacific cod in the Western 
Regulatory Area

AGENCY: National Marine Fisheries Service (NMFS), National Oceanic and 
Atmospheric Administration (NOAA), Commerce.

ACTION: Closure.

-----------------------------------------------------------------------

SUMMARY: NMFS is prohibiting retention of Pacific cod in the Western 
Regulatory Area of the Gulf of Alaska (GOA). NMFS is requiring that 
catches of Pacific cod in the Western Regulatory Area be treated in the 
same manner as prohibited species and discarded at sea with a minimum 
of injury. This action is necessary because the total allowable catch 
(TAC) of Pacific cod in this area has been reached.

EFFECTIVE DATE: 12 noon, Alaska local time (A.l.t.), May 5, 1996, until 
12 midnight A.l.t., December 31, 1996.

FOR FURTHER INFORMATION CONTACT: Mary Furuness, 907-586-7228.

SUPPLEMENTARY INFORMATION: The groundfish fishery in the GOA exclusive 
economic zone is managed by NMFS according to the Fishery Management 
Plan for Groundfish of the Gulf of Alaska (FMP) prepared by the North 
Pacific Fishery Management Council under authority of the Magnuson 
Fishery Conservation and Management Act. Fishing by U.S. vessels is 
governed by regulations implementing the FMP at 50 CFR parts 620 and 
672.
    In accordance with Sec. 672.20(c)(1)(ii)(B), the TAC for Pacific 
cod in the Western Regulatory Area was established by the Final 1996 
Harvest Specifications of Groundfish (61 FR 4304, February 5, 1996) as 
18,850 metric tons (mt).
    The Director, Alaska Region, NMFS, has determined, in accordance 
with Sec. 672.20(c)(3), that the TAC for Pacific cod in the Western 
Regulatory Area of the GOA has been reached. Therefore, NMFS is 
requiring that further catches of Pacific cod in the Western Regulatory 
Area of the GOA be treated as prohibited species in accordance with 
Sec. 672.20(e).

Classification

    This action is taken under 50 CFR 672.20 and is exempt from review 
under E.O. 12866.

    Authority: 16 U.S.C. 1801 et seq.

    Dated: May 3, 1996.
Richard W. Surdi,
Acting Director, Office of Fisheries Conservation and Management, 
National Marine Fisheries Service.
[FR Doc. 96-11547 Filed 5-3-96; 4:47 pm]
BILLING CODE 3510-22-F
**EXHIBIT 32.02**

**Section 1350 Certification**

In connection with thisquarterly report of ML Appleton FuturesAccess LLC (the “Company”) on Form 10-Qfor the period ended March 31, 2007 as filed with the Securities ExchangeCommission on the date hereof (this “Report”), I, Barbra E. Kocsis, ChiefFinancial Officer of Merrill Lynch Alternative Investments LLC, the manager ofML Appleton FuturesAccess LLC, certify, pursuant to 18 U.S.C. Section 1350, asadopted pursuant of the Sarbanes-Oxley Act of 2002, that:

1. This Report fullycomplies with the requirements of Section 13(a) or 15(d) of the SecuritiesExchange Act of 1934; and

2. The informationcontained in this Report fairly presents, in all material respects, thefinancial condition and results of operations of the Company.

 

Date:  May 15, 2007

| By                                           | /s/ BARBRA E. KOCSIS |   |
|----------------------------------------------|----------------------|--------|
| Barbra E. Kocsis                             |
| Chief Financial Officer                      |
| (Principal Financial and Accounting Officer) |

 

----
**Exhibit32.1**

**CERTIFICATIONOF CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

Inconnection with the Quarterly Report on Form 10-Q of Aviza Technology, Inc.(the “Company”), the undersigned Chief Executive Officer of the Companycertifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant toSection 906 of the Sarbanes-Oxley Act of 2002, that, to his knowledge:

(1)                                  the accompanying report on Form 10-Q of theCompany for the quarter ended December 29, 2006, as filed with the Securitiesand Exchange Commission (the “Report”), fully complies with therequirements of Section 13(a) or 15(d) of the Securities Exchange Act of1934, as amended; and

(2)                                  the information contained in the Reportfairly presents, in all material respects, the financial condition and resultsof operations of the Company for the periods presented therein.

Date:February 5, 2007
|   | By:    | /s/ Jerauld J.  Cutini                 |   |
|--------|--------|----------------------------------------|--------|
|   |   | Jerauld J.  Cutini                     |
|   |   | President and  Chief Executive Officer |

 

----
EXHIBIT 31.3

CERTIFICATION OF CHIEF EXECUTIVE OFFICER

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Laurent Fischer, M.D., certify that:



| | 1. | I have reviewed this Amendment No. 1 to Quarterly Report on Form 10-Q of Tobira Therapeutics, Inc.; and
| | -- | -------------------------------------------------------------------------------------------------------



| | 2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such
statements were made, not misleading with respect to the period covered by this report.
| | -- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

Date: July 22, 2016



|                                                     
|-----------------------------------------------------
|/s/ Laurent Fischer,
M.D.                            
|Laurent Fischer, M.D.                                
|                                                     
|                                                     
|Chief Executive Officer (Principal Executive
Officer)
|
EXHIBIT 32.2



CERTIFICATION OF

CHIEF FINANCIAL OFFICER

PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002



I, Thomas Scannell, Chief Financial Officer, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
2002, that the Annual Report of Sirenza Microdevices, Inc. on Form 10-K for the fiscal year ended December 31, 2004 fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934 and that information contained
in such Annual Report on Form 10-K fairly presents in all material respects the financial condition and results of operations of Sirenza Microdevices, Inc.



Date: March 3, 2005

/s/ THOMAS SCANNELLName: Thomas Scannell Title: Chief Financial Officer
EXHIBIT 32


                          SECTION 1350 CERTIFICATIONS

                  CERTIFICATION PURSUANT TO 18 U.S.C. SECTION
                1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE
                           SARBANES-OXLEY ACT OF 2002


     In connection with the annual  report of ICrystal,  Inc. (the "Company")
on Form  10-KSB  for the  period  ended  December 31,  2003 as filed  with the
Securities and Exchange  Commission on the date hereof (the "Report"),  I, Larry
J. Hrabi, CEO, Chairman and CFO of the Company,  certify,  pursuant to 18 U.S.C.
section 1350, as adopted  pursuant to Section 906 of the  Sarbanes-Oxley  Act of
2002, that based on my knowledge:

     1. The Report fully  complies  with the  requirements  of Section  13(a) or
15(d) of the Securities Exchange Act of 1934; and

     2. The information contained in the Report fairly presents, in all material
respects, the financial condition and results of operations of the Company.


Date: April 14, 2004


/s/ LARRY J. HRABI
______________________________________
Larry J. Hrabi
CEO,
Chairman and CFO





A SIGNED  ORIGINAL OF THIS WRITTEN  STATEMENT  REQUIRED BY SECTION 906, OR OTHER
DOCUMENT AUTHENTICATING, ACKNOWLEDGING, OR OTHERWISE ADOPTING THE SIGNATURE THAT
APPEARS IN TYPED FORM WITHIN THE  ELECTRONIC  VERSION OF THIS WRITTEN  STATEMENT
REQUIRED  BY  SECTION  906,  HAS BEEN  PROVIDED  TO  ICRYSTAL, INC. AND WILL BE
RETAINED  BY  ICRYSTAL, INC.  AND  FURNISHED  TO THE  SECURITIES  AND  EXCHANGE
COMMISSION OR ITS STAFF UPON REQUEST.